https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Medicenna_Therapeutics_Corp.Medicenna Therapeutics Corp. - Revizia istoricului2026-04-05T21:16:59ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Medicenna_Therapeutics_Corp.&diff=429879&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Medicenna Therapeutics Corp. listata cu simbolul US.MDNA ==Descriere companie== Medicenna Therapeutics Corp. (https://www.medicenna.com) is a clinical stage immunotherapy company. The Company is primarily engaged in the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its Bi-functional...2024-09-18T18:11:51Z<p>Pagină nouă: Pagina dedicata companiei Medicenna Therapeutics Corp. listata cu simbolul US.MDNA ==Descriere companie== Medicenna Therapeutics Corp. (https://www.medicenna.com) is a clinical stage immunotherapy company. The Company is primarily engaged in the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its Bi-functional...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Medicenna Therapeutics Corp. listata cu simbolul US.MDNA<br />
<br />
==Descriere companie==<br />
Medicenna Therapeutics Corp. (https://www.medicenna.com) is a clinical stage immunotherapy company. The Company is primarily engaged in the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its Bi-functional SuperKine ImmunoTherapies (BiSKITs) platform is designed to enable the ability of Superkines to treat immunologically cold tumors. The Company’s product candidate MDNA55, is an Empowered Superkine developed as a therapeutic for recurrent glioblastoma multiforme (rGBM), a fatal form of brain cancer. MDNA11, an IL-2 Superkine that has been fused with human recombinant albumin. The Company has not earned any revenues from its products.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.MDNA" /><br />
<br />
==Ultimele stiri despre Medicenna Therapeutics Corp. (US.MDNA)==<br />
<dynamicpagelist><br />
category=US.MDNA<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.MDNA]][[Categorie:Stiri despre companii]]</div>Admin